Clinical trials
Observational Carcinoma, Non-Small-Cell Lung trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 5 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 8 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Samsung Medical Center | 7 |
| AstraZeneca | 4 |
| Boehringer Ingelheim | 2 |
| Hoffmann-La Roche | 2 |
| National Cancer Centre, Singapore | 2 |
| Yonsei University | 2 |
| AbbVie | 1 |
| Bristol-Myers Squibb | 1 |
| Chonnam National University Hospital | 1 |
| Ethicon Endo-Surgery | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 34 |
| Lung Neoplasms | 3 |
| Adenocarcinoma of Lung | 1 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Transitional Cell | 1 |
| Esophageal Neoplasms | 1 |
| Head and Neck Neoplasms | 1 |
| Neoplasms | 1 |
| Ovarian Neoplasms | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.